Stock Fundamentals

Company Information

▼
Company Name
ESSA Pharma Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA29668H7085
CIK: 0001633932
CUSIP: 29668H708
Currency: USD
Full Time Employees: 35
Phone: 778 331 0962
Website: https://www.essapharma.com
Fiscal Year End: September
IPO Date: Jul 09, 2015
Description:

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. As of October 9, 2025, ESSA Pharma Inc. operates as a subsidiary of Alexis Bio, Inc.

Address:

999 West Broadway, Vancouver, BC, Canada, V5Z 1K5

Directors & Officers

▼
Name Title Year Born
Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA Chief Financial Officer 1957
Nkengyal Barber Executive NA
Steve Pondell Executive NA
Terry Schuenemeyer Executive NA
Dr. Roger Ulrich Ph.D. Consultant NA
Dr. Jim Bristol Consultant NA
Ms. Kim Hewitt Consultant NA
Dr. Stephen Plymate M.D. Consultant NA
Kally Singh Consultant NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Bvf Inc 8.75M Jun 30, 2025 18.49% $0.53 0.00%
TANG CAPITAL MANAGEMENT LLC 4.30M Jun 30, 2025 9.09% $0.37 0.00%
BML Capital Management LLC 4.22M Jun 30, 2025 8.92% $5.43 0.00%
Morgan Stanley - Brokerage Accounts 4.21M Jun 30, 2025 8.90% $0.00 -2.10%
Soleus Capital Management, L.P. 2.26M Jun 30, 2025 4.78% $0.25 0.00%
Opaleye Management Inc 2.21M Jun 30, 2025 4.67% $0.76 0.00%
Pfizer Inc 1.68M Jun 30, 2025 3.54% $0.49 0.00%
Altium Capital Management, LP 1.05M Mar 31, 2025 2.22% $4.00 -26.44%
Bank of America Corp 627.93K Jun 30, 2025 1.33% $0.00 -10.07%
Aldebaran Capital LLC 578.94K Jun 30, 2025 1.22% $0.97 1.69%
DLD Asset Management, LP 314.97K Jun 30, 2025 0.67% $0.04 71.50%
BNP Paribas Arbitrage, SA 271.20K Jun 30, 2025 0.57% $0.00 15.21%
Two Sigma Advisers, LLC 260.80K Jun 30, 2025 0.55% $0.00 -5.54%
Two Sigma Investments LLC 222.33K Jun 30, 2025 0.47% $0.00 -20.35%
LMR Partners LLP 200.00K Jun 30, 2025 0.42% $0.00 0.00%
JPMorgan Chase & Co 189.09K Jun 30, 2025 0.40% $0.00 14.69%
Group One Trading, LP 83.82K Jun 30, 2025 0.18% $0.00 296.93%
Magnus Financial Group LLC 55.21K Jun 30, 2025 0.12% $0.01 0.00%
Citadel Advisors Llc 54.04K Jun 30, 2025 0.11% $0.00 -34.20%
ADAR1 Capital Management LLC 50.00K Jun 30, 2025 0.11% $0.01 0.00%

Shares Statistics

▼
Shares Outstanding: 47.31M
Shares Float: 33.36M
% Insiders: 561.70%
% Institutions: 7,370.20%
Short % Float: 3.62%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Bvf Inc 8.75M 18.49% ▲ 0.00% Jun 30, 2025
2 TANG CAPITAL MANAGEMENT LLC 4.30M 9.09% ▲ 0.00% Jun 30, 2025
3 BML Capital Management LLC 4.22M 8.92% ▲ 0.00% Jun 30, 2025
4 Morgan Stanley - Brokerage Accounts 4.21M 8.90% ▼ 2.10% Jun 30, 2025
5 Soleus Capital Management, L.P. 2.26M 4.78% ▲ 0.00% Jun 30, 2025
6 Opaleye Management Inc 2.21M 4.67% ▲ 0.00% Jun 30, 2025
7 Pfizer Inc 1.68M 3.54% ▲ 0.00% Jun 30, 2025
8 Altium Capital Management, LP 1.05M 2.22% ▼ 26.44% Mar 31, 2025
9 Bank of America Corp 627.93K 1.33% ▼ 10.07% Jun 30, 2025
10 Aldebaran Capital LLC 578.94K 1.22% ▲ 1.69% Jun 30, 2025

Valuation Metrics

▼
Enterprise Value: $-99.33M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $9.52M
EBITDA: $-23.50M
PEG Ratio: $0.00
Book Value: $2.45
Dividend/Share: $0.00
Dividend Yield: 87.56%
Earnings/Share: $-0.57
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -15.25%
ROE (TTM): -21.25%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-09-30 38.64x 0.00x 0.03x N/A -0.01x
2023-09-30 42.57x 0.00x 0.02x -4,628.94x 0.00x
2022-09-30 73.38x 0.00x 0.01x -2,524.48x 0.00x
2021-09-30 50.28x 0.00x 0.02x -1,661.05x 0.00x
2020-09-30 66.92x 0.00x 0.02x -37.40x 0.00x
2019-09-30 9.82x 0.08x 0.10x -20.15x -0.31x
2018-09-30 4.79x 0.69x 0.43x -11.84x -0.59x
2017-09-30 1.48x -1.86x 1.76x -14.84x -2.24x
2016-09-30 2.87x -0.23x 1.05x -20.94x -0.01x
2015-09-30 2.30x 0.00x 0.41x -119.74x 0.00x
2014-09-30 1.72x 0.00x 0.53x -20.83x 0.00x
2013-09-30 1.34x 0.00x 0.27x N/A 0.00x
2012-09-30 7.43x 0.00x 0.09x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 05, 2025 Bvf Partners L P/Il N/A Sale 156.00 $1.88 $293.28
Nov 01, 2024 Growth N. V. Biotech N/A Sale 7.88M $1.53 $12.06M

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EPIX.US!